These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 8450045)
1. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease. van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045 [TBL] [Abstract][Full Text] [Related]
3. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease. Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847 [TBL] [Abstract][Full Text] [Related]
4. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells. Choy FY; Wei C; Levin D Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741 [TBL] [Abstract][Full Text] [Related]
5. The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C. Salvioli R; Tatti M; Scarpa S; Moavero SM; Ciaffoni F; Felicetti F; Kaneski CR; Brady RO; Vaccaro AM Biochem J; 2005 Aug; 390(Pt 1):95-103. PubMed ID: 15826241 [TBL] [Abstract][Full Text] [Related]
6. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues. Choy FY Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386 [TBL] [Abstract][Full Text] [Related]
7. Mutations causing Gaucher disease. Horowitz M; Zimran A Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460 [TBL] [Abstract][Full Text] [Related]
8. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Ron I; Horowitz M Hum Mol Genet; 2005 Aug; 14(16):2387-98. PubMed ID: 16000318 [TBL] [Abstract][Full Text] [Related]
9. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease. Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231 [TBL] [Abstract][Full Text] [Related]
10. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts. Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642 [TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728 [TBL] [Abstract][Full Text] [Related]
12. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts. Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391 [TBL] [Abstract][Full Text] [Related]
13. Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model. Lamghari M; Barrias CC; Sá Miranda C; Barbosa MA Blood Cells Mol Dis; 2005; 35(3):348-54. PubMed ID: 16125984 [TBL] [Abstract][Full Text] [Related]
14. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303 [TBL] [Abstract][Full Text] [Related]
15. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients. Sa Miranda MC; Aerts JM; Pinto R; Fontes A; de Lacerda LW; van Weely S; Barranger J; Tager JM Clin Genet; 1990 Sep; 38(3):218-27. PubMed ID: 2225530 [TBL] [Abstract][Full Text] [Related]
16. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease. Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918 [TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value. Boot RG; Hollak CE; Verhoek M; Sloof P; Poorthuis BJ; Kleijer WJ; Wevers RA; van Oers MH; Mannens MM; Aerts JM; van Weely S Hum Mutat; 1997; 10(5):348-58. PubMed ID: 9375849 [TBL] [Abstract][Full Text] [Related]
19. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease. van Weely S; Brandsma M; Strijland A; Tager JM; Aerts JM Biochim Biophys Acta; 1993 Mar; 1181(1):55-62. PubMed ID: 8457606 [TBL] [Abstract][Full Text] [Related]